Getting started with
TAZVERIK® (tazemetostat)

The first and only FDA-approved therapy specifically for epithelioid sarcoma

TAZVERIK is a prescription medicine used to treat adults and children aged 16 years and older with epithelioid sarcoma that has spread or grown and cannot be removed by surgery.

The approval of TAZVERIK in these patients is based on a study that measured the percentage of patients whose tumor shrank or disappeared after treatment and how long that response lasted. TAZVERIK is still being studied to confirm these benefits.

It is not known if TAZVERIK is safe and effective in children less than 16 years of age.

Living with epithelioid sarcoma and want to learn more about TAZVERIK?

Learn how

Discover what TAZVERIK is and how it works.

Learn more about safety & study results

Learn more about the possible results and side effects you may see with TAZVERIK.

Learn more
about dosing & administration

Learn more about recommended dosing and how to take TAZVERIK.

Learn about patient & product support programs for eligible patients

Learn more about EpizymeNOW Patient and Product Support.